Results 191 to 200 of about 581,453 (310)
Postpartum Management of Placenta Accreta with Transcervical Radiofrequency Ablation for Fertility Conservation. [PDF]
Santella N, Toub D, Hansen Lindner L.
europepmc +1 more source
Vaginal host–microbe signatures linked to placental outcomes in mares
Abstract Background Ascending placentitis is a leading cause of late‐term pregnancy loss in mares. Although pathogens are presumed to ascend from the caudal reproductive tract, the association between the vaginal microbiome and placentitis has not been systematically examined.
Machteld van Heule +7 more
wiley +1 more source
Reconciling the Use of Human Fetal Tissue in Research
Annals of the Child Neurology Society, EarlyView.
Harvey B. Sarnat +4 more
wiley +1 more source
A New Vista of Opportunity in Diabetes Management: Natural Product‐Based β‐cell Preservation
Preserving functional β‐cells via natural products offers promising strategy for diabetes treatment. ABSTRACT A defining characteristic of diabetes is β‐cell failure, in which β‐cells cannot modulate insulin secretion to compensate for escalating insulin resistance, pushing forward disease development.
Yi‐San Lee +4 more
wiley +1 more source
Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing. [PDF]
Bowman CJ +11 more
europepmc +1 more source
Unexpected Placenta Accreta Spectrum During Cesarean Section: Intraoperative Diagnosis and Life-Saving Surgical Management. [PDF]
Mouna A, Rim B, Khaliud F, Samir B.
europepmc +1 more source
ABSTRACT Pediatric cancer is a significant cause of morbidity and mortality in children. The etiologies of pediatric cancer are largely unknown, but environmental pesticide exposures are likely to contribute. Chronic low‐dose exposure to pesticide mixtures through drinking water is a growing concern in agricultural communities.
Grace N. VanDeSteeg +4 more
wiley +1 more source
Placental transport dysfunction in omega-3 and omega-6 fatty acid in patients with gestational diabetes mellitus. [PDF]
Long W +6 more
europepmc +1 more source
Antiangiogenic treatment with ramucirumab is a standard second‐line option in advanced gastric and gastroesophageal junction adenocarcinoma. However, reliable biomarkers are currently lacking. This exploratory biomarker analysis of the RAMIRIS trial suggests that elevated baseline and early on‐treatment levels of the pro‐angiogenic placental growth ...
Jurek Hille +17 more
wiley +1 more source

